By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Synthetic Cooling Compounds in E-Cigarettes Linked to Cardiac Arrhythmias

Synthetic Cooling Compounds in E-Cigarettes Linked to Cardiac Arrhythmias

GMJ
Last updated: 07/07/2026 22:43
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Scientific illustration of heart rhythm monitoring related to e-cigarette research
Laboratory study finds synthetic cooling ingredients in e-cigarettes cause abnormal heart rhythms in mice and human heart cells. Research published in Circulation raises safety concerns about vaping additives. — "Heart Monitor" by medipics1066 is marked with Public Domain Mark 1.0. To view the terms, visit https://creativecommons.org/publicdomain/mark/1.0/. (Public Domain Mark)
SHARE
1 min read|132 words

New research published in Circulation: Arrhythmia and Electrophysiology has identified a concerning cardiovascular risk associated with popular e-cigarette additives. Scientists discovered that synthetic cooling ingredients—compounds designed to mimic menthol sensations—trigger abnormal heart rhythms in laboratory models.

The study employed dual experimental approaches, testing cooling agents on both living mouse models and isolated human cardiac cells cultured in laboratory settings. Both systems demonstrated similar patterns of cardiac dysfunction when exposed to these compounds, suggesting a consistent physiological response.

These findings expand our understanding of vaping-related health risks beyond nicotine addiction. The research reveals that cooling agents disrupt normal electrical conduction in heart tissue, potentially increasing cardiovascular risk in users. As e-cigarette use continues globally, these results underscore the importance of comprehensive ingredient safety evaluation.

Read the full article on GMJ Newsroom.

Submit Your Paper
GMJ_Submit_Banner

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: E-cigarette cooling ingredients linked to heart rhythm disorders in lab study →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Gene Therapy Shows Promise for Inherited Cholesterol Disorder in First-in-Human Trial

First-in-human gene therapy trial shows preliminary safety and efficacy for treating homozygous…

Teen Drug Use and Binge Drinking Linked to Severe Mental Health Crisis

UCLA research reveals dangerous links between teen substance use and mental health…

PFAS ‘Forever Chemicals’ Persist in Ski Wax Rooms Despite Regulatory Bans

New research reveals PFAS 'forever chemicals' persist in ski wax facilities years…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Healthcare professional discussing medical safety and screening guidelines

Announcement: Health Expert Addresses Rising Peptide Use, Colorectal Cancer Screening Gaps, and Ebola Preparedness

By
Prof. Giorgi Pkhakadze
07/06/2026
Medical professionals in operating room demonstrating surgical safety protocols with tranexamic acid

Low-Cost Antifibrinolytic Drug Shows Promise in Reducing Surgical Bleeding Worldwide

By
Prof. Giorgi Pkhakadze
04/07/2026
Bronchoscopic view showing black carbon deposits in bronchial airways from coal dust exposure

Recognizing Bronchial Anthracosis: What Occupational Health Professionals Should Know

By
Prof. Giorgi Pkhakadze
30/06/2026

SITUATION BRIEF: Ebola Cross-Border Transmission – DRC to Uganda, PHEIC Declared

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up